Combination of radiation, chemotherapy, and immunotherapy can shrink tumors and allow surgery, with much better survival rate rather than with non-surgical treatment alone. In some cases of advanced esophageal cancer that are considered to...
Animals with longer gestation times may have fewer cancers, but the way traits relate to cancer risk is complex. Cancer occurs in animals as well as in humans, at widely varying rates among different...
The study, published in an AACR journal, comes after an FDA warning regarding the potential for secondary malignancies after CAR T cells are used for B-cell lymphoma or multiple myeloma. Patients who receive CAR...
Immunotherapy may make surgery an option for patients who would be considered ineligible under traditional rules. Surgery is usually the best treatment for early-stage hepatocellular carcinoma, the most common type of liver cancer, but...
Patients given waivers to participate in A trial had outcomes the same or slightly better than people who met the standard requirements; findings support broader and more inclusive trial designs. Cancer patients sometimes find...
Transgender and gender nonconforming people are most likely to have continuing conditions, regardless of age, race and ethnicity, smoking history, and socioeconomic status, according to A study. Of people who have survived cancer, those...
Kinase inhibitor trametinib may spare patients from intensive treatments, such as stem cell transplant, for An aggressive form of blood cancer in Small Children. Researchers say they have found a new way to treat...
Less frequent HPV tests detect precancerous lesions of the cervix just as well as more frequent Pap smears, which could help achieve The goal of eliminating the cancer. When it comes to detecting precancerous...
Improvements in medical care have reduced the rate of relapse in acute myeloid leukemia after transplants, helped people live longer, and reduced mortality from other causes, according to large set of data. Older patients...
Non-invasive scanning for biomarkers after only 1 week may guide treatment for some patients with melanoma and avoid surgery in other patients. Imaging may help determine if the immunotherapeutic pembrolizumab (Keytruda) is helping patients with...
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn MoreYour donation to the American Association for Cancer Research helps our more than 58,000 members worldwide drive progress against cancer.
Donate Now